Get 20% lifetime commission for referring investors to digrin.com
here.
Outlook Therapeutics, Inc. ( OTLK) - Key Metrics
OTLK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | -$0.15 | $0 | $0 |
| 2026Q2 | $0 | -$0.05 | -$0.10 | -$0.10 |
| 2026Q1 | -$0.02 | -$0.38 | -$0.25 | -$0.25 |
| 2025Q4 | $0 | -$0.38 | -$0.36 | -$0.36 |
| 2025Q3 | $0.04 | -$0.55 | -$0.32 | -$0.32 |
OTLK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -2.65 |
| 2026Q2 | 0% | -0.95 |
| 2026Q1 | 0% | -1.04 |
| 2025Q4 | 0% | -0.70 |
| 2025Q3 | 0% | -0.73 |
OTLK
Price: $0.70
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.13 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 308347
Market Capitalization: 141.4 million